Jeffrey Hessekiel, EVP and General Counsel of Exelixis, Inc. ($EXEL), made one open market sale of $EXEL shares worth $1.15 million in the last year, with the most recent on May 15, 2025. This ranks him 4,588th among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | CYTOKINETICS INC | $CYTK | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Incentive Stock Option (Right to Buy) | 8325 | $0.00 | 8,325.0000 | 122,264,929 | 9999.99% | 0.01% |
| March 15, 2026 | CYTOKINETICS INC | $CYTK | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Non-Qualified Stock Option (Right to Buy) | 22820 | $0.00 | 22,820.0000 | 122,264,929 | 9999.99% | 0.02% |
| March 15, 2026 | CYTOKINETICS INC | $CYTK | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Common Stock | 20646 | $0.00 | 107,943.0000 | 122,264,929 | 23.65% | 0.02% |
| Nov. 14, 2025 | CYTOKINETICS INC | $CYTK | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Common Stock | 87297 | $0.00 | 87,297.0000 | 122,264,929 | 9999.99% | 0.07% |
| May 15, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | S | Common Stock | 25000 | $46.18 | 694,395.0000 | 296,132,000 | 3.48% | 0.01% |
| May 15, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | F | Common Stock | 34035 | $44.65 | 719,395.0000 | 296,132,000 | 4.52% | 0.01% |
| March 31, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | A | Common Stock | 154070 | $0.00 | 752,677.0000 | 296,132,000 | 25.74% | 0.05% |
| Feb. 26, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | A | Common Stock | 52192 | $0.00 | 598,607.0000 | 296,132,000 | 9.55% | 0.02% |
| Feb. 15, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | F | Common Stock | 18134 | $35.00 | 546,415.0000 | 296,132,000 | 3.21% | 0.01% |
| Jan. 16, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | F | Common Stock | 26289 | $37.27 | 564,549.0000 | 296,132,000 | 4.45% | 0.01% |
| Jan. 16, 2025 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | A | Common Stock | 118780 | $0.00 | 590,838.0000 | 296,132,000 | 25.16% | 0.04% |
| Nov. 27, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | F | Common Stock | 98908 | $35.93 | 547,058.0000 | 296,994,000 | 15.31% | 0.03% |
| Nov. 29, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | S | Common Stock | 60000 | $36.67 | 487,058.0000 | 296,994,000 | 10.97% | 0.02% |
| Nov. 29, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | G | Common Stock | 15000 | $0.00 | 472,058.0000 | 296,994,000 | 3.08% | 0.01% |
| Nov. 27, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | M | Option (right to buy) | 129314 | $0.00 | 0.0000 | 296,994,000 | 100.00% | 0.04% |
| Nov. 27, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | M | Common Stock | 129314 | $18.80 | 645,966.0000 | 296,994,000 | 25.03% | 0.04% |
| Nov. 15, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | F | Common Stock | 14672 | $35.05 | 516,652.0000 | 296,994,000 | 2.76% | 0.00% |
| Nov. 1, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | S | Common Stock | 50000 | $34.13 | 531,324.0000 | 296,994,000 | 8.60% | 0.02% |
| Oct. 28, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | S | Common Stock | 25000 | $28.39 | 581,324.0000 | 296,994,000 | 4.12% | 0.01% |
| Sept. 23, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP & General Counsel | S | Common Stock | 25000 | $26.38 | 606,324.0000 | 321,464,000 | 3.96% | 0.01% |
| Aug. 26, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Common Stock | 20000 | $24.41 | 651,324.0000 | 321,464,000 | 3.17% | 0.01% |
| Aug. 26, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 20000 | $25.79 | 631,324.0000 | 321,464,000 | 3.07% | 0.01% |
| Aug. 26, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Option (right to buy) | 20000 | $0.00 | 0.0000 | 321,464,000 | 100.00% | 0.01% |
| Aug. 7, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 80000 | $25.97 | 631,324.0000 | 321,464,000 | 11.25% | 0.02% |
| Aug. 7, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Common Stock | 80000 | $24.41 | 711,324.0000 | 321,464,000 | 12.67% | 0.02% |
| Aug. 7, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Option (right to buy) | 80000 | $0.00 | 20,000.0000 | 321,464,000 | 80.00% | 0.02% |
| May 15, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 8600 | $20.99 | 641,425.0000 | 321,464,000 | 1.32% | 0.00% |
| May 15, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 7240 | $20.99 | 650,025.0000 | 321,464,000 | 1.10% | 0.00% |
| May 15, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 10101 | $20.99 | 631,324.0000 | 321,464,000 | 1.57% | 0.00% |
| Feb. 23, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | A | Common Stock | 63350 | $0.00 | 656,051.0000 | 321,464,000 | 10.69% | 0.02% |
| Jan. 11, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 13061 | $22.86 | 592,701.0000 | 321,464,000 | 2.16% | 0.00% |
| Jan. 11, 2024 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | A | Common Stock | 71418 | $0.00 | 605,762.0000 | 321,464,000 | 13.37% | 0.02% |
| Dec. 13, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 25000 | $23.01 | 534,344.0000 | 324,556,000 | 4.47% | 0.01% |
| Nov. 30, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 25000 | $22.01 | 584,344.0000 | 324,556,000 | 4.10% | 0.01% |
| Dec. 4, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 25000 | $22.06 | 559,344.0000 | 324,556,000 | 4.28% | 0.01% |
| Sept. 6, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | A | Common Stock | 57900 | $0.00 | 623,698.0000 | 324,556,000 | 10.23% | 0.02% |
| Sept. 6, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 14354 | $22.27 | 609,344.0000 | 324,556,000 | 2.30% | 0.00% |
| Aug. 15, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 7177 | $21.51 | 565,798.0000 | 324,556,000 | 1.25% | 0.00% |
| Aug. 1, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Common Stock | 55710 | $14.74 | 628,685.0000 | 324,556,000 | 9.72% | 0.02% |
| Aug. 1, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 55710 | $19.63 | 572,975.0000 | 324,556,000 | 8.86% | 0.02% |
| Aug. 1, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Option (right to buy) | 55710 | $0.00 | 0.0000 | 324,556,000 | 100.00% | 0.02% |
| May 15, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 4940 | $19.18 | 580,002.0000 | 324,556,000 | 0.84% | 0.00% |
| May 15, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 7027 | $19.18 | 572,975.0000 | 324,556,000 | 1.21% | 0.00% |
| April 3, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | A | Common Stock | 79719 | $0.00 | 608,434.0000 | 324,556,000 | 15.08% | 0.02% |
| April 5, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Common Stock | 13930 | $14.74 | 622,364.0000 | 324,556,000 | 2.29% | 0.00% |
| April 5, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 38930 | $20.01 | 583,434.0000 | 324,556,000 | 6.26% | 0.01% |
| April 5, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Option (right to buy) | 13930 | $0.00 | 55,710.0000 | 324,556,000 | 20.00% | 0.00% |
| March 1, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Common Stock | 27860 | $14.74 | 606,575.0000 | 324,556,000 | 4.81% | 0.01% |
| March 1, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | S | Common Stock | 77860 | $17.13 | 528,715.0000 | 324,556,000 | 12.84% | 0.02% |
| March 1, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | M | Option (right to buy) | 27860 | $0.00 | 69,640.0000 | 324,556,000 | 28.57% | 0.01% |
| Feb. 15, 2023 | EXELIXIS, INC. | $EXEL | Hessekiel Jeffrey | EVP, General Counsel & Sec | F | Common Stock | 1929 | $18.08 | 578,715.0000 | 324,556,000 | 0.33% | 0.00% |